Anomalous origin of left main coronary artery from right coronary artery in a patient presenting with inferior wall myocardial infarction: a case report and literature review

por Ludhwani, Dipesh, Woo, Vincent
Publicado 2019

Emerging use of combination therapies for the management of type 2 diabetes – focus on saxagliptin and dapagliflozin

por Yu, Huan, Woo, Vincent C
Publicado 2017

Behavioral Health Order Sets in a Hybrid Information Environment

por Strauss, John, Olbrycht, Peggy, Woo, Vincent
Publicado 2013

Understanding the Clinical Profile of Insulin Degludec, the Latest Basal Insulin Approved for Use in Canada: a Narrative Review

por Woo, Vincent, Berard, Lori, Roscoe, Robert
Publicado 2020

Safety and efficacy of early atropine injection for dobutamine stress cardiac magnetic resonance: a single center experience

por Woo, Vincent, Lau, Stanley, Pohost, Gerald M
Publicado 2011

Insulin degludec/liraglutide (IDegLira) for the treatment of type 2 diabetes

por Gough, Stephen CL, Jain, Rajeev, Woo, Vincent C
Publicado 2016

Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes

por List, James F., Woo, Vincent, Morales, Enrique, Tang, Weihua, Fiedorek, Fred T.
Publicado 2009

A Rare Case of RYR2 Mutation Causing Sudden Cardiac Arrest Due to Catecholaminergic Polymorphic Ventricular Tachycardia

por Vemireddy, Lalitha Padmanabha, Aqeel, Ammar, Ying, Grace W, Majlesi, Delaram, Woo, Vincent
Publicado 2021

Greater Combined Reductions of HbA(1c) ≥ 1.0% and Body Weight Loss ≥ 5.0% or ≥ 10.0% with Orally Administered Semaglutide Versus Comparators

por Dungan, Kathleen M., Bardtrum, Lars, Christiansen, Erik, Eliasson, Johanna, Mellbin, Linda, Woo, Vincent C., Vilsbøll, Tina
Publicado 2023

Achieving glycaemic control without weight gain, hypoglycaemia, or gastrointestinal adverse events in type 2 diabetes in the SUSTAIN clinical trial programme

por DeVries, J. Hans, Desouza, Cyrus, Bellary, Srikanth, Unger, Jeffrey, Hansen, Oluf K. H., Zacho, Jeppe, Woo, Vincent
Publicado 2018

Short‐term cost‐utility of degludec versus glargine U100 for patients with type 2 diabetes at high risk of hypoglycaemia and cardiovascular events: A Canadian setting (DEVOTE 9)...

por Pollock, Richard F., Heller, Simon, Pieber, Thomas R., Woo, Vincent, Gundgaard, Jens, Hallén, Nino, Luckevich, Maria, Tutkunkardas, Deniz, Zinman, Bernard
Publicado 2019

Superior weight loss with once-weekly semaglutide versus other glucagon-like peptide-1 receptor agonists is independent of gastrointestinal adverse events

por Lingvay, Ildiko, Hansen, Thomas, Macura, Stanislava, Marre, Michel, Nauck, Michael A, de la Rosa, Raymond, Woo, Vincent, Yildirim, Emre, Wilding, John
Publicado 2020

IDegLira Improves Both Fasting and Postprandial Glucose Control as Demonstrated Using Continuous Glucose Monitoring and a Standardized Meal Test

por Holst, Jens J., Buse, John B., Rodbard, Helena W., Linjawi, Sultan, Woo, Vincent C., Boesgaard, Trine Welløv, Kvist, Kajsa, Gough, Stephen C.
Publicado 2015

Abstract 15: Glycemic and body weight responses to oral semaglutide in the PIONEER trial program

por Kumar, K B Sharan, Dungan, Kathleen M, Hertz, Christin L, Mellibin, Linda, Nielsen, Morten Abildlund, Sorrig, Rasmus, Woo, Vincent C, Vilsboll, Tina
Publicado 2022

Use of once‐weekly semaglutide in patients with type 2 diabetes in routine clinical practice: Results from the SURE Canada multicentre, prospective, observational study

por Yale, Jean‐François, Catarig, Andrei‐Mircea, Grau, Katrine, Harris, Stewart, Klimek‐Abercrombie, Agnieszka, Rabasa‐Lhoret, Rémi, Reardon, Laura, Woo, Vincent, Liutkus, Joanne
Publicado 2021

Fibrous Cap Thickness Predicts Stable Coronary Plaque Progression: Early Clinical Validation of a Semiautomated OCT Technology

por Kassis, Nicholas, Kovarnik, Tomas, Chen, Zhi, Weber, Joseph R., Martin, Brendan, Darki, Amir, Woo, Vincent, Wahle, Andreas, Sonka, Milan, Lopez, John J.
Publicado 2022

Assessing the impact of a new delivery method of insulin on glycemic control using a novel trial design

por Strack, Thomas, Martinez, Luc, Del Prato, Stefano, Blonde, Larry, Göke, Burkhard, Woo, Vincent, Millward, Ann, Gomis, Ramon, Canovatchel, Bill, Lawrence, David, Freemantle, Nick
Publicado 2009

Investigating the Association Between Baseline Characteristics (HbA1c and Body Mass Index) and Clinical Outcomes of Fast-Acting Insulin Aspart in People with Diabetes: A Post Hoc A...

por Bowering, Keith, Rodbard, Helena W., Russell-Jones, David, Bode, Bruce, Harris, Stewart, Piletic, Milivoj, Heller, Simon, Woo, Vincent, Babu, Vinay, Dethlefsen, Claus, Mathieu, Chantal
Publicado 2018

CANadian CAnagliflozin REgistry: Effectiveness and safety of canagliflozin in the treatment of type 2 diabetes mellitus in Canadian clinical practice

por Woo, Vincent, Bell, Alan, Clement, Maureen, Noronha, Luis, Tsoukas, Michael A., Camacho, Fernando, Traina, Shana, Georgijev, Natasha, Culham, Matthew D., Rose, Jennifer B., Rapattoni, Wally, Bajaj, Harpreet S.
Publicado 2018

Sequential drug treatment algorithm for agitation and aggression in Alzheimer’s and mixed dementia

por Davies, Simon JC, Burhan, Amer M, Kim, Donna, Gerretsen, Philip, Graff-Guerrero, Ariel, Woo, Vincent L, Kumar, Sanjeev, Colman, Sarah, Pollock, Bruce G, Mulsant, Benoit H, Rajji, Tarek K
Publicado 2018